PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $15,001,000 | -21.3% | 399,496 | 0.0% | 3.16% | +15.8% |
| Q2 2017 | $19,056,000 | +4.6% | 399,496 | 0.0% | 2.73% | +9.2% |
| Q1 2017 | $18,217,000 | -27.3% | 399,496 | -48.5% | 2.50% | -45.4% |
| Q4 2016 | $25,045,000 | -5.6% | 775,388 | 0.0% | 4.58% | -5.4% |
| Q3 2016 | $26,534,000 | +1.5% | 775,388 | 0.0% | 4.84% | +36.2% |
| Q2 2016 | $26,154,000 | -38.9% | 775,388 | -4.0% | 3.55% | -16.8% |
| Q1 2016 | $42,789,000 | -24.7% | 807,650 | +9.1% | 4.27% | +7.8% |
| Q4 2015 | $56,825,000 | +94.7% | 740,000 | +4.2% | 3.96% | +92.3% |
| Q3 2015 | $29,181,000 | -4.2% | 710,000 | +64.9% | 2.06% | +19.6% |
| Q2 2015 | $30,447,000 | +21.4% | 430,535 | +52.5% | 1.72% | +12.0% |
| Q1 2015 | $25,081,000 | +1755.1% | 282,284 | +1750.8% | 1.54% | +2037.5% |
| Q4 2014 | $1,352,000 | +143.2% | 15,252 | +166.1% | 0.07% | +140.0% |
| Q3 2014 | $556,000 | +5.5% | 5,732 | 0.0% | 0.03% | -9.1% |
| Q2 2014 | $527,000 | -39.1% | 5,732 | -53.6% | 0.03% | -59.3% |
| Q1 2014 | $865,000 | +64.1% | 12,366 | +35.0% | 0.08% | +107.7% |
| Q4 2013 | $527,000 | – | 9,160 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |